ENTITY
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals (REGN US)

128
Analysis
Health CareUnited States
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
more
bullishInmode
28 Feb 2022 16:21Syndicated

Top Picks for Growth Stocks - Feb 2022

The market has been quite volatile these past couple of months. Unfortunately, it seems like volatility will stay for some time.

Logo
191 Views
Share
x